Listening to biology’s early whispers
Interpreted multimodal monitoring—epigenetic clocks, proteomics, wearables—to detect chronic disease risk years before symptoms, while flagging cost, noise, reimbursement and regulatory barriers.
Why it mattersCell perspective from the Buck Institute implies payers must design reimbursement models for longitudinal multi-omic surveillance.